TABLE 1.
Demographic, anthropometric, and biochemical characteristics of the study cohorts1
| Greece | Spain |
United States |
Singapore |
|||||
| Harokopio Study, general population | EPIGEM, general population | PREDIMED Valencia, high CVD risk | GOLDN Study, white non-Hispanics | BPR-CPHHD, Puerto Rican Hispanics | SNHS-98, Chinese | SNHS-98, Malays | SNHS-98, Asian Indians | |
| n (M/F) | 0/351 | 768/854 | 184/353 | 508/553 | 226/582 | 1018/1240 | 309/315 | 225/244 |
| Age (y) | 47.7 ± 122 | 41.9 ± 14 | 67.1 ± 6 | 48.4 ± 16 | 58 ± 7 | 37.8 ± 12 | 38.7 ± 12 | 40.5 ± 12 |
| BMI (kg/m2) | 29.1 ± 5 | 26.1 ± 4 | 31.6 ± 5 | 28.2 ± 5 | 32.2 ± 8 | 22.6 ± 4 | 25.5 ± 5 | 25.1 ± 5 |
| Triacylglycerol (mg/dL) | 98.4 ± 49 | 111.0 ± 64 | 130.7 ± 67 | 132.1 ± 81 | 150 ± 78 | 117.6 ± 68 | 139.8 ± 83 | 141.6 ± 78 |
| HDL-C (mg/dL) | 51.7 ± 11 | 50.6 ± 11 | 51.3 ± 12 | 47.2 ± 13 | 45.3 ± 12 | 55.2 ± 14 | 50.2 ± 13 | 44.4 ± 12 |
| LDL-C (mg/dL) | 148.3 ± 35 | 131.2 ± 34 | 131.0 ± 31 | 121.6 ± 31 | 107.2 ± 35 | 130.5 ± 36 | 148.3 ± 38 | 142.9 ± 40 |
| Fasting blood glucose (mg/dL) | 97.3 ± 17 | 95.7 ± 23 | 128.6 ± 43 | 101.3 ± 18 | 122.8 ± 52 | 100.9 ± 22 | 109.3 ± 38 | 112.2 ± 38 |
1
EPIGEM, Epidemiología Genética y Molecular; PREDIMED, Prevención con Dieta Mediterránea; GOLDN, Genetics of Lipid Lowering Drugs and Diet Network; BPR-CPHHD, Boston Puerto Rican Health Study–Centers on Population Health and Health Disparities; SNHS-98, Singapore National Health Survey of 1998; CVD, cardiovascular disease; HDL-C, HDL cholesterol; LDL-C, LDL cholesterol.
2
Mean ± SD (all such values).